MedEsthetics magazines offers business education and in-depth coverage of the latest noninvasive cosmetic procedures for physicians and practice managers working in the medical aesthetics industry.
Issue link: https://medesthetics.epubxp.com/i/156138
NEWS & EVENTS University of Minnesota Medical School, medical director of Crutchfield Dermatology, and a member of the AOA National Medical Honor Society. YORK NAMED CEO OF SENTE Michale York has been named CEO and president of Sente, a privately held medical skincare company based on glycoproteins. York brings more than 20 years of management experience at Santarus, Amgen and AstraZeneca to the position. "We are delighted to welcome Mr. York, a wellrespected commercial leader in the healthcare industry, as president and CEO of Sente. His strategic vision and extensive experience in healthcare operation, marketing and finance will make him an invaluable member of the Sente team," said Faheem Hasnain, chairman of the Sente board of directors. "We are confident that under his leadership we will be well positioned to take advantage of the fastgrowing medical cosmetic market and allow the company to emerge as a major contender in the space." COCKERELL NAMED MEDICAL DIRECTOR OF SENSUS HEALTHCARE Clay Cockerell has been named medical director of Sensus Healthcare, a provider of noninvasive skin cancer and keloid scar treatment technologies. Dr. Cockerell will lead the company's medical advisory board. "I am excited to be involved with Sensus and for the opportunity to see the ongoing development of dermatologic radiotherapy. This is an excellent technique that provides a very good supplement in select patients to the excellent dermatologic surgical techniques, including Mohs Surgery, that we routinely employ," said Dr. Cockerell, who is a practicing dermatologist and dermatopathologist in Dallas, Texas. He is the director of Cockerell and Associates Dermpath Diagnostics Laboratories, clinical professor of Dermatology and Pathology and director of Dermatopathology at the University of Texas Southwestern Medical Center. IN MEMORIAM The world of clinical skin care has lost two of its innovators and pioneers. Dermatologist and founder of Vivant Skin Care James Edwin Fulton, Jr., MD, died on July 4, 2013, at the age of 73. "Jim devoted his life to dermatology and his passing will leave a void in the world of skin care," JAMES EDWIN FULTON, JR., MD said Sara Fulton, his wife and CEO of Vivant. "He achieved much during his career, but his greatest contributions may have been the hope and 72 SEPTEMBER/OCTOBER 2013 | MedEsthetics confidence he instilled in his acne patients." Dr. Fulton's interest in dermatology stemmed from the acne struggles he endured as a pre-teen and throughout adulthood. He earned his Bachelor of Science and Doctor of Medicine degrees from Tulane University in 1965. While in residency at the Hospital of the University of Pennsylvania, Dr. Fulton met his close friend and mentor Dr. Albert Kligman; together they co-developed Retin-A, a topical form of vitamin A. In the early 1970s, with his wife Sara, Dr. Fulton launched a successful chain of 12 acne clinics called Acne Healthcare Centers, opened the Acne Research Institute and developed and manufactured a line of patented skincare products under the AHC and Face Up brands. He was among the first dermatologists to use estheticians in the medical office developing a paramedical aesthetician training program. In 1990, Dr. Fulton opened JEF Medical Group, a cosmetic surgery and dermatology practice where he pioneered the use of fat transfer and laser surgery and was the first to use hyperbaric oxygen chambers for post-surgical recovery. In addition, Dr. Fulton and Sara co-founded Vivant Skin Care in 1990, a clinical skin care line rooted in Dr. Fulton's patented vitamin A therapies. Sheldon Pinnell, MD, eminent scientist, dermatologist and leading scientist behind L'Oreal-owned SkinCeuticals died in Durham, North Carolina on July 4, 2013, at the age of 76. Dr. Pinnell was a J. Lamar Callaway Professor Emeritus of Dermatology and Chief Emeritus of the Division of Dermatology at Duke University. His investigative research helped changed the way the world uses topical antioxidants today. He was the first to patent a stable form of vitamin C proven SHELDON PINNELL, MD through peer-reviewed research to effectively penetrate skin, delivering eight times the skin's natural antioxidant protection. Before helping to shape the cosmeceutical industry, Dr. Pinnell led major advances in the understanding of skin biology and the pathogenesis of skin diseases. Early in his career, he made seminal contributions to the understanding of Ehlers-Danlos Syndrome and the role of vitamin C in collagen biosynthesis. Dr. Pinnell has been globally recognized for his contributions to science and skincare, most recently receiving an honorary membership to the Society for Investigative Dermatology. "It is our greatest privilege to have been able to help Dr. Pinnell bring his discovery of topical antioxidants to life. Prior to the introduction of topical vitamin C in the early 1990s, skincare professionals were largely limited to sunscreens to protect against the deleterious effects of the sun. It was Dr. Pinnell who gave the medical community the confidence to transform the approach to at-home skincare...His life